XML 61 R51.htm IDEA: XBRL DOCUMENT
v3.23.1

COMMITMENTS AND CONTINGENCIES (Details) |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Apr. 01, 2019 USD ($) | Dec. 19, 2012 USD ($) | Mar. 31, 2023 USD ($) Facility Center Term | Mar. 31, 2022 USD ($) | Dec. 31, 2021 Facility
Vendor and Licensor Commitments [Abstract] |  |  |  |  |
Number of FDA-licensed plasma collection facilities approved | Facility |  |  | 5 |  |
Number of FDA Inspections | Facility |  |  |  |  | 2
Plasma supply agreement term |  |  | 10 years |  |
Plasma purchased from Grifols |  |  | $ 11,600,000 | $ 15,500,000 |
Percentage of inventory purchases |  |  | 40.00% | 75.00% |
Post-Marketing Commitments [Abstract] |  |  |  |  |
Research and Development Expense | $ 1,500,000 |  | $ 855,351 | $ 624,111 |
BIVIGAM [Member] |  |  |  |  |
Post-Marketing Commitments [Abstract] |  |  |  |  |
Research and Development Expense |  |  | 400,000 | 400,000 |
ASCENIV [Member] |  |  |  |  |
Post-Marketing Commitments [Abstract] |  |  |  |  |
Research and Development Expense |  |  | $ 200,000 | $ 100,000 |
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | International Customers [Member] |  |  |  |  |
Vendor and Licensor Commitments [Abstract] |  |  |  |  |
Concentration risk, percentage |  |  | 7.00% | 6.00% |
Minimum [Member] |  |  |  |  |
Post-Marketing Commitments [Abstract] |  |  |  |  |
Research and Development Expense |  | $ 1,500,000 |  |  |
Maximum [Member] |  |  |  |  |
Post-Marketing Commitments [Abstract] |  |  |  |  |
Research and Development Expense |  | $ 2,000,000 |  |  |
2011 Plasma Purchase Agreement [Member] |  |  |  |  |
Vendor and Licensor Commitments [Abstract] |  |  |  |  |
Plasma purchase agreement term |  |  | 10 years |  |
Number of renewal terms | Term |  |  | 2 |  |
Plasma purchase agreement renewal period |  |  | 5 years |  |
Number of plasma collection centers that collects RSV Plasma which were transferred to BPC | Center |  |  | 2 |  |
Percentage of plasma purchase price equal to cost |  |  | 5.00% |  |
2011 Plasma Purchase Agreement [Member] | Maximum [Member] |  |  |  |  |
Vendor and Licensor Commitments [Abstract] |  |  |  |  |
Number of plasma collection facilities | Facility |  |  | 5 |  |
2017 Plasma Purchase Agreement [Member] |  |  |  |  |
Vendor and Licensor Commitments [Abstract] |  |  |  |  |
Number of plasma collection facilities | Facility |  |  | 10 |  |

X
- Definition Number of FDA inspections completed during the period. + References No definition available. + Details
Name: | adma_NumberOfFDAInspections
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of plasma collection facilities having FDA licenses approved. + References No definition available. + Details
Name: | adma_NumberOfFDALicensedPlasmaCollectionFacilitiesApproved
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of plasma collection centers that company may purchase RSV plasma. + References No definition available. + Details
Name: | adma_NumberOfPlasmaCollectionCentersTransferredToAcquiredEntity
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of wholly-owned plasma collection facilities of the entity. + References No definition available. + Details
Name: | adma_NumberOfPlasmaCollectionFacilities
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of renewal terms to extend purchase agreement, if agreed to by the parties. + References No definition available. + Details
Name: | adma_NumberOfRenewalTerms
Namespace Prefix: | adma_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of inventory purchases related to raw material plasma. + References No definition available. + Details
Name: | adma_PercentageOfInventoryPurchases
Namespace Prefix: | adma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of plasma purchase price equal to cost purchased from collection centers. + References No definition available. + Details
Name: | adma_PercentageOfPlasmaPurchasePriceEqualToCost
Namespace Prefix: | adma_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Plasma purchase agreement renewal period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_PlasmaPurchaseAgreementRenewalPeriod
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Plasma purchase agreement term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_PlasmaPurchaseAgreementTerm
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of plasma purchased during the period. + References No definition available. + Details
Name: | adma_PlasmaPurchased
Namespace Prefix: | adma_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Plasma supply agreement term period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | adma_PlasmaSupplyAgreementTerm
Namespace Prefix: | adma_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | adma_PostMarketingCommitmentsAbstract
Namespace Prefix: | adma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | adma_VendorAndLicensorCommitmentsAbstract
Namespace Prefix: | adma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 912 -SubTopic 730 -Section 25 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=adma_BIVIGAMMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=adma_ASCENIVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=adma_InternationalCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adma_PlasmaPurchaseAgreementOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adma_PlasmaPurchaseAgreementTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |